Sign In
Buy SDZNY
$79.34
-0.468 (-0.586%)
At Close: Jun 03, 2026
Here's Why Sandoz Group AG Sponsored ADR (SDZNY) Is a Great 'Buy the Bottom' Stock Now
10:57am, Monday, 16'th Dec 2024
Sandoz Group AG Sponsored ADR (SDZNY) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate rev
SDZNY vs. ZTS: Which Stock Is the Better Value Option?
12:46pm, Wednesday, 04'th Dec 2024
Investors looking for stocks in the Medical - Drugs sector might want to consider either Sandoz Group AG Sponsored ADR (SDZNY) or Zoetis (ZTS). But which of these two companies is the best option for
SDZNY vs. ZTS: Which Stock Should Value Investors Buy Now?
12:41pm, Monday, 18'th Nov 2024
Investors with an interest in Medical - Drugs stocks have likely encountered both Sandoz Group AG Sponsored ADR (SDZNY) and Zoetis (ZTS). But which of these two stocks offers value investors a better
Agomab Announces the Appointment of Former Sandoz CFO Colin Bond to its Board of Directors
05:00am, Monday, 18'th Nov 2024
ANTWERP, Belgium--(BUSINESS WIRE)--Agomab Therapeutics NV (‘Agomab') today announced the appointment of Colin Bond to the company's Board of Directors as a non-executive Director and Chairman of the
Sandoz receives European Commission approval for Afqlir® (aflibercept), further strengthening leading biosimilar portfolio
01:00am, Friday, 15'th Nov 2024
MEDIA RELEASE Afqlir® (aflibercept) approved to treat various retinal diseases, including neovascular age-related macular degeneration (nAMD) One of several biosimilar value drivers for Sandoz Sandoz
SDZNY or ZTS: Which Is the Better Value Stock Right Now?
12:45pm, Friday, 01'st Nov 2024
Investors interested in stocks from the Medical - Drugs sector have probably already heard of Sandoz Group AG Sponsored ADR (SDZNY) and Zoetis (ZTS). But which of these two stocks offers value investo
Sandoz reports third-quarter and nine-month 2024 sales
02:00am, Wednesday, 30'th Oct 2024
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules MEDIA RELEASE Strong third-quarter biosimilars growth of 37% in constant currencies from existing portfolio and recent launches
Sandoz US launches generic paclitaxel in single-dose vial, further expanding US oncology portfolio
01:00am, Friday, 11'th Oct 2024
MEDIA RELEASE First FDA-approved abbreviated new drug application (ANDA) to reference medicine Single-dose 100 mg vial for intravenous use, approved for metastatic breast cancer Launch expected to be
Sandoz Canada achieves carbon neutral certification for its commercial operations
08:00am, Monday, 07'th Oct 2024
BOUCHERVILLE, Quebec, Oct. 07, 2024 (GLOBE NEWSWIRE) -- Sandoz Canada obtained carbon neutral certification from the engineering consulting firm LCL Engineering, Environment & Sustainable Development
SDZNY or ZTS: Which Is the Better Value Stock Right Now?
12:46pm, Monday, 30'th Sep 2024
Investors with an interest in Medical - Drugs stocks have likely encountered both Sandoz Group AG Sponsored ADR (SDZNY) and Zoetis (ZTS). But which of these two stocks presents investors with the bett
SDZNY vs. ZTS: Which Stock Is the Better Value Option?
12:40pm, Friday, 13'th Sep 2024
Investors with an interest in Medical - Drugs stocks have likely encountered both Sandoz Group AG Sponsored ADR (SDZNY) and Zoetis (ZTS). But which of these two companies is the best option for those
SDZNY or ZTS: Which Is the Better Value Stock Right Now?
12:41pm, Wednesday, 28'th Aug 2024
Investors looking for stocks in the Medical - Drugs sector might want to consider either Sandoz Group AG Sponsored ADR (SDZNY) or Zoetis (ZTS). But which of these two stocks presents investors with th
Axsome Therapeutics Reaches Agreement to Dismiss Sunosi® (Solriamfetol) Patent Litigation with Sandoz Inc.
07:00am, Wednesday, 21'st Aug 2024
NEW YORK, Aug. 21, 2024 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system
SDZNY vs. STVN: Which Stock Is the Better Value Option?
12:47pm, Monday, 12'th Aug 2024
Investors with an interest in Medical - Drugs stocks have likely encountered both Sandoz Group AG Sponsored ADR (SDZNY) and Stevanato Group (STVN). But which of these two companies is the best option
Sandoz receives FDA approval for Enzeevu™ (aflibercept-abzv), further strengthening US biosimilar position
01:00am, Monday, 12'th Aug 2024
Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules Enzeevu™ (aflibercept-abzv) approved to treat neovascular age-related macular degeneration Further enhances leading US ophtha
